Please assess the completion status of the following clinical trial:

Trial Title: Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy male subjects age between 19 and 55 signed informed consent~Exclusion Criteria:~* subjects have a history of allergy reaction of this drug or other drugs

- Gender: MALE
- Minimum Age: 19 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- NVP-1205 (Type: EXPERIMENTAL): administration of NVP-1205(rosuvastatin+ezetimibe)
- rosuvastatin and ezetimibe (Type: ACTIVE_COMPARATOR): coadministration of rosuvastatin and ezetimibe

Based on this trial design, predict the completion outcome and termination type (if applicable).